Thieno[2,3-d]pyrimidine-3-acetic acids a new class of nonpeptide endothelin receptor antagonists

Nobuo Cho, Yoshi Nara, Mioko Harada, Tsukasa Sugo, Yasushi Masuda, Akemi Abe, Keiji Kusumoto, Yasuaki Itoh, Tetsuya Ohtaki, Toshifumi Watanabe, Shuichi Furuya

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)


On the basis of structural information for the cyclic hexapeptide endothelin (ET) receptor antagonist, TAK-044, a series of thieno[2,3- d]pyrimidine-2,4-dione derivatives bearing a carboxyl group and aromatic rings that were important for receptor binding were designed, synthesized, and evaluated for ET receptor binding affinities and inhibitory activities against ET-induced vasoconstriction. Optimization of each substituent in the thieno[2,3-d]pyrimidine ring led to the discovery of a novel and potent nonpeptide ET receptor antagonist, 6-(4-methoxymethoxyphenyl)-5- methylsulfonylaminomethyl-1-(2-methylthiobenzyl)-2,4-dioxo-1,2,3,4- tetrahydrothieno[2,3-d]pyrimidine-3-acetic acid (32g), which binded to human ET(A) and ET(B) receptor subtypes with affinities (IC50) of 7.6 and 100 nM, respectively. Compound 32 g effectively antagonized ET-induced vasoconstriction and the inhibitory effect mediated by the ET(B) receptor was more potent than that of bosentan, while the inhibitory effect mediated by the ET(A) receptor was slightly less potent than that of bosentan.

Original languageEnglish
Pages (from-to)1724-1737
Number of pages14
JournalChemical and Pharmaceutical Bulletin
Issue number11
Publication statusPublished - 1998
Externally publishedYes


  • Bosentan
  • ET-induced vasoconstriction
  • Endothelin receptor antagonist
  • Endothelin receptor binding affinity
  • Thieno[2,3-d]pyrimidine-3-acetic acid

ASJC Scopus subject areas

  • Chemistry(all)
  • Drug Discovery


Dive into the research topics of 'Thieno[2,3-d]pyrimidine-3-acetic acids a new class of nonpeptide endothelin receptor antagonists'. Together they form a unique fingerprint.

Cite this